Asper Biotech
Asper Biotech has updated its Ashkenazi Jewish Diseases Test to include mutations in the BRCA1, BRCA2, and LCA5 genes that are common in the Ashkenazi Jewish population. Asper's test now detects up to 112 variants in 27 genes.
Asper Biotech recently introduced a number of new test panels targeted to mitochondrial diseases.
Asper Biotech recently launched a new carrier test to detect the most common mutations associated with autosomal recessive disorders that are overrepresented in the Hutterite population.
From its office in Tartu, Estonia, Asper Biotech continues to introduce new microarray-based tests related to reproductive health, oncology, and opthamalogy.
Asper Biotech recently launched a test for Leber hereditary optic neuropathy, or LHON, a disease characterized by optic nerve dysfunction that leads to painless, subacute loss of central vision.
Jan 3, 2012
Sep 13, 2011
Sep 6, 2011
New Product Watch: Sep 6, 2011
Premium
Jun 28, 2011
New Product Watch: Jun 28, 2011
Premium
Mar 8, 2011
New Product Watch: Mar 8, 2011
Premium
Sep 15, 2009